Ferrer's Jorge Gonzalez on Predictive Toxicology Strategy

Posted: 01/13/2013

It is very important to capitalise on innovative developments and implement the latest in-vitro and in-silico models to address the continual challenge of in-vitro and in-vivo extrapolation. In this Pharma IQ interview we are joined by Jorge I. González Borroto, senior toxicologist for pharmacology and safety at Ferrer

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Posted: 01/13/2013


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018